BIDIMENSIONAL LINKED MATRIX FACTORIZATION FOR PAN-OMICS PAN-CANCER ANALYSIS

Several modern applications require the integration of multiple large data matrices that have shared rows and/or columns. For example, cancer studies that integrate multiple omics platforms across multiple types of cancer, , have extended our knowledge of molecular heterogeneity beyond what was obse...

Full description

Saved in:
Bibliographic Details
Published inThe annals of applied statistics Vol. 16; no. 1; p. 193
Main Authors Lock, Eric F, Park, Jun Young, Hoadley, Katherine A
Format Journal Article
LanguageEnglish
Published United States 01.03.2022
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Several modern applications require the integration of multiple large data matrices that have shared rows and/or columns. For example, cancer studies that integrate multiple omics platforms across multiple types of cancer, , have extended our knowledge of molecular heterogeneity beyond what was observed in single tumor and single platform studies. However, these studies have been limited by available statistical methodology. We propose a flexible approach to the simultaneous factorization and decomposition of variation across such matrices, BIDIFAC+. BIDIFAC+ decomposes variation into a series of low-rank components that may be shared across any number of row sets (e.g., omics platforms) or column sets (e.g., cancer types). This builds on a growing literature for the factorization and decomposition of linked matrices which has primarily focused on multiple matrices that are linked in one dimension (rows or columns) only. Our objective function extends nuclear norm penalization, is motivated by random matrix theory, gives a unique decomposition under relatively mild conditions, and can be shown to give the mode of a Bayesian posterior distribution. We apply BIDIFAC+ to pan-omics pan-cancer data from TCGA, identifying shared and specific modes of variability across different omics platforms and 29 different cancer types.
ISSN:1932-6157
DOI:10.1214/21-AOAS1495